LaFrence Andrew D.C.

Track

Insider profile

LaFrence Andrew D.C.'s trades of Cancer Genetics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
127.56
Quantity 43,835 -12.8%
Value US$2,945,546
Transaction date
Purchase
Price
249.16
Quantity 10,206 +42.2%
Value US$4,973,743
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-11-24 2021-11-23
B Purchase
43,835 -12.8%
127.56
US$2,945,546 		43,835 -12.8% 127.56 US$2,945,546
2021-05-21 2021-05-20
B Purchase
10,206 +42.2%
249.16
US$4,973,743 		10,206 +42.2% 249.16 US$4,973,743